Next Article in Journal
Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
Next Article in Special Issue
Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine
Previous Article in Journal
Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer
Open AccessReview

Affibody Molecules as Targeting Vectors for PET Imaging

by Vladimir Tolmachev 1,2,* and Anna Orlova 2,3,4
1
Department of Immunology, Genetics and Pathology, Uppsala University, 75185 Uppsala, Sweden
2
Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia
3
Department of Medicinal Chemistry, Uppsala University, 75183 Uppsala, Sweden
4
Science for Life Laboratory, Uppsala University, 75237 Uppsala, Sweden
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(3), 651; https://doi.org/10.3390/cancers12030651
Received: 14 February 2020 / Revised: 6 March 2020 / Accepted: 9 March 2020 / Published: 11 March 2020
(This article belongs to the Special Issue Cancer Molecular Imaging)
Affibody molecules are small (58 amino acids) engineered scaffold proteins that can be selected to bind to a large variety of proteins with a high affinity. Their small size and high affinity make them attractive as targeting vectors for molecular imaging. High-affinity affibody binders have been selected for several cancer-associated molecular targets. Preclinical studies have shown that radiolabeled affibody molecules can provide highly specific and sensitive imaging on the day of injection; however, for a few targets, imaging on the next day further increased the imaging sensitivity. A phase I/II clinical trial showed that 68Ga-labeled affibody molecules permit an accurate and specific measurement of HER2 expression in breast cancer metastases. This paper provides an overview of the factors influencing the biodistribution and targeting properties of affibody molecules and the chemistry of their labeling using positron emitters. View Full-Text
Keywords: PET; affibody molecules; HER2; EGFR; molecular imaging; radiolabeling PET; affibody molecules; HER2; EGFR; molecular imaging; radiolabeling
Show Figures

Figure 1

MDPI and ACS Style

Tolmachev, V.; Orlova, A. Affibody Molecules as Targeting Vectors for PET Imaging. Cancers 2020, 12, 651.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop